Brief: Hamlet Pharma Q1 pre-tax loss widens to SEK 4.1 mln
02/11/2017 08:09
Nov 2 (Reuters) - HAMLET PHARMA AB HAMLET.ST :
* Q1 PRE-TAX LOSS AT SEK 4.1 MILLION VERSUS LOSS SEK 1.6
MILLION
YEAR AGO
Source text for Eikon: ID:nNDL3wrB9T
Further company coverage: HAMLET.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 587720920;))
Recent news on Hamlet BioPharma AB
See all newsBrief: Hamlet Biopharma Announces Completion Of Alpha1h Phase Ii Study In Non-Muscle Invasive Bladder Cancer
Brief: Hamlet Biopharma Holds Successful In Person Meeting With US FDA
Brief: Hamlet Pharma Q2 Loss Before Tax Narrows To SEK 2.8 Mln
Brief: Hamlet Pharma Gets Patent In Europe
Brief: Hamlet Pharma Gets Patent Granted In Europe